111 related articles for article (PubMed ID: 14632775)
1. Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome.
Rubio MT; Dhedin N; Boucheix C; Bourhis JH; Reman O; Boiron JM; Gallo JH; Lhéritier V; Thomas X; Fière D; Vernant JP
Br J Haematol; 2003 Dec; 123(5):842-9. PubMed ID: 14632775
[TBL] [Abstract][Full Text] [Related]
2. Aggressive chemotherapy for acute leukemia relapsed after bone marrow transplantation: a second chance?
Sica S; Di Mario A; Pagano L; Etuk B; Salutari P; Leone G
Acta Haematol; 1992; 87(4):173-5. PubMed ID: 1519431
[TBL] [Abstract][Full Text] [Related]
3. Biphenotypic acute leukaemia: a case series.
Aribi A; Bueso-Ramos C; Estey E; Estrov Z; O'Brien S; Giles F; Faderl S; Thomas D; Kebriaei P; Garcia-Manero G; Pierce S; Cortes J; Kantarjian H; Ravandi F
Br J Haematol; 2007 Jul; 138(2):213-6. PubMed ID: 17593028
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
Paciucci PA; Cuttner J; Holland JF
Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
[TBL] [Abstract][Full Text] [Related]
5. Adult acute leukaemia.
Atkinson K; Wells DG; Clink HM; Kay HE; Powles R; McElwain TJ
Br J Cancer; 1974 Sep; 30(3):272-8. PubMed ID: 4141625
[TBL] [Abstract][Full Text] [Related]
6. Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.
Laszlo D; Agazzi A; Goldhirsch A; Cinieri S; Bertolini F; Rabascio C; Pruneri G; Calabrese L; Cocquio A; Martinelli G
Eur J Haematol; 2004 Apr; 72(4):264-7. PubMed ID: 15089764
[TBL] [Abstract][Full Text] [Related]
7. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
Pituch-Noworolska A
Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
[TBL] [Abstract][Full Text] [Related]
8. Aggressive chemotherapy for acute leukemia relapsed after transplantation.
Sica S; Salutari P; Di Mario A; D'Onofrio G; Etuk B; Leone G
Leuk Lymphoma; 1994 Sep; 15(1-2):131-4. PubMed ID: 7858490
[TBL] [Abstract][Full Text] [Related]
9. DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study.
Dudler C; Bargetzi M; Tichelli A; Gratwohl A; Passweg JR; Wernli M
Eur J Haematol; 2009 Dec; 83(6):512-8. PubMed ID: 19614953
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of various types of acute leukemia in adult. An analysis of 98 cases. The Leukemia Cooperation Group of Beijing City].
Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):139-42, 187. PubMed ID: 1395923
[TBL] [Abstract][Full Text] [Related]
11. Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.
Krug U; Röllig C; Koschmieder A; Heinecke A; Sauerland MC; Schaich M; Thiede C; Kramer M; Braess J; Spiekermann K; Haferlach T; Haferlach C; Koschmieder S; Rohde C; Serve H; Wörmann B; Hiddemann W; Ehninger G; Berdel WE; Büchner T; Müller-Tidow C; ;
Lancet; 2010 Dec; 376(9757):2000-8. PubMed ID: 21131036
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
Colović M; Bogdanović A; Janković G; Kraguljac N; Suvajdzić N
Chemotherapy; 2003 Jun; 49(3):138-45. PubMed ID: 12815207
[TBL] [Abstract][Full Text] [Related]
13. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
14. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
[TBL] [Abstract][Full Text] [Related]
15. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
Ribera JM; Grañena A; Rozman C; Urbano-Ispizua A; Bladé J; Carreras E; Cervantes F; Marín P; Sierra J; Nomdedeu B
Sangre (Barc); 1990 Feb; 35(1):26-32. PubMed ID: 2333581
[TBL] [Abstract][Full Text] [Related]
16. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis.
Hanson CA; Abaza M; Sheldon S; Ross CW; Schnitzer B; Stoolman LM
Br J Haematol; 1993 May; 84(1):49-60. PubMed ID: 7687860
[TBL] [Abstract][Full Text] [Related]
17. A systematic collaborative overview of randomized trials comparing idarubicin with daunorubicin (or other anthracyclines) as induction therapy for acute myeloid leukaemia. AML Collaborative Group.
Br J Haematol; 1998 Oct; 103(1):100-9. PubMed ID: 9792296
[TBL] [Abstract][Full Text] [Related]
18. Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.
Schoch C; Haferlach T; Haase D; Fonatsch C; Löffler H; Schlegelberger B; Staib P; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
Br J Haematol; 2001 Jan; 112(1):118-26. PubMed ID: 11167792
[TBL] [Abstract][Full Text] [Related]
19. Conventional and high-dose daunorubicin and idarubicin in acute myeloid leukaemia remission induction treatment: a mixed treatment comparison meta-analysis of 7258 patients.
Sekine L; Morais VD; Lima KM; Onsten TG; Ziegelmann PK; Ribeiro RA
Hematol Oncol; 2015 Dec; 33(4):212-9. PubMed ID: 25363800
[TBL] [Abstract][Full Text] [Related]
20. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]